Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Capivasertib
Study Purpose: This study was done to learn about the safety
of capivasertib given with existing medicines
in men who had prostate cancer that had
spread to other parts of the body.
Protocol Number: D3618C00002
Thank you
Thank you for taking part in the clinical study for the study drug capivasertib, also
called AZD5363.
AstraZeneca AB sponsored this study and believes it is important to share the
results. An independent non-profit organization called CISCRP helped prepare
this summary of the study results for you.
If you participated in the study and have questions about the results, please
speak with the study doctor or staff at your study site.
1